Amgen (AMGN) ebitda was $11.7B in FY2025 (+33% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$11.7B
+33%
2024
$8.8B
-13%
2023
$10.0B
-7%
2022
$10.8B
-5%
2021
$11.4B
-10%
2020
$12.7B
+4%
2019
$12.2B
-3%
2018
$12.5B
+2%
2017
$12.3B
+3%
2016
$12.0B
+8%
2015
$11.0B
+22%
2014
$9.1B
+20%
2013
$7.6B
+8%
2012
$7.0B
+23%
2011
$5.7B
-17%
2010
$6.9B
+1%
2009
$6.9B
+3%
2008
$6.6B
+22%
2007
$5.4B
Recent Quarterly EBITDA
Quarter
EBITDA
Q1 2026
$3.0B
Q4 2025
$3.1B
Q3 2025
$3.3B
Q2 2025
$3.0B
Q1 2025
$2.3B
Q4 2024
$2.7B
Q3 2024
$2.4B
Q2 2024
$2.3B
Q1 2024
$1.4B
Q4 2023
$611M
Q3 2023
$2.8B
Q2 2023
$3.5B
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.